Stock Trim Losses -...
Health Care: Health Services
Boston Scientific Inc. (BSX: NYSE)
$9.06 -0.10 | -1.15%
05/24/13 - 10:35 AM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with BSX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorMost-Active Stocks for the ...
- ContributorMost-Active Stocks for the ...
- Contributor10 Profitable and Oversold ...
- Userjennydog
- ProLeon Cooperman - Omega Advi...
- ContributorHealth Care Stocks Bought a...
- Contributor6 Stocks Purchased by Billi...
- Contributor8 Health Care Stocks Inside...
- UserPFE
Latest BSX Headlines from TheStreet
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner 05.20.13 | 05:05 pm
- Cramer's Top Stock Picks: BSX BAX FB 05.18.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 05.17.13 | 08:05 pm
- 'Mindless' Picks: RIM, Molycorp
05.14.13 | 02:05 pm - 5 Stocks Boosting The Health Services Industry Higher 05.13.13 | 01:05 pm
- Analysts' Actions: MU BSX CVC FRX 05.10.13 | 08:05 am
- Cramer's 'Mad Money' Recap: Looking for Real Leaders 05.09.13 | 08:05 pm
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner 05.09.13 | 05:05 pm
- 5 Health Services Stocks Nudging The Industry Higher 05.09.13 | 01:05 pm
- 5 Stocks Moving The Health Services Industry Upward 04.25.13 | 01:04 pm
Press Releases for BSX
- New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessixâ¿¢ Renal Denervation System - PR Newswire 05.22.13 | 12:05 pm
- Boston Scientific Reports Lotusâ¿¢ Valve System Met Primary Performance Endpoint In REPRISE II Trial - PR Newswire 05.22.13 | 10:05 am
- Boston Scientific Promus PREMIERâ¿¢ And SYNERGYâ¿¢ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data - PR Newswire 05.22.13 | 09:05 am
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out To Five Years In Patients With Severe Asthma - PR Newswire 05.21.13 | 11:05 am
- OrbusNeich Seizes Boston Scientific Stents In Germany As Part Of Patent Infringement Proceedings - PR Newswire 05.21.13 | 05:05 am
- Boston Scientific Presents Clinical Data At Digestive Disease Week® - PR Newswire 05.17.13 | 09:05 am
- Boston Scientific Schedule Of Major Events And Presentations At EuroPCR 2013 - PR Newswire 05.17.13 | 03:05 am
- First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Drainage In Patients With Pancreatic Or Periampullary Cancers - PR Newswire 05.15.13 | 12:05 pm
- OrbusNeich Obtains Additional Preliminary Injunction Against Boston Scientific In Germany - PR Newswire 05.14.13 | 03:05 am
- Boston Scientific Receives CE Mark Approval For The Rhythmiaâ¿¢ Mapping System - PR Newswire 05.10.13 | 09:05 am
Partner Headlines for BSX
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Olympus: climbing a mountain - Financial Times 02.12.13 | 12:02 pm
- St. Jude to Repurchase $1B Shares - Analyst Blog - Zacks 11.30.12 | 05:11 pm
- After Hours Most Active for Nov 20, 2012 : BAC, HPQ, IHG, QQQ, ONNN, BX, BSX, GNW, MSFT, CSTR, SPLS, PBCT - NASDAQ 11.20.12 | 09:11 pm
- Medtronic Earnings Solid, Guidance Cautious - Investor's Business Daily 11.20.12 | 04:11 pm
- St. Jude Remains Neutral - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- Greatbatch Beats Ests, Profits Dip - Analyst Blog - Zacks 10.26.12 | 05:10 pm
- Stryker to Expand, Aims Surpass - Analyst Blog - Zacks 10.19.12 | 04:10 pm
- Obamacare Can Learn From These Healthcare Stocks - Seeking Alpha 10.19.12 | 09:10 am
- Boston Scientific: Earnings Decline Coupled With A Weak Market Outlook - Seeking Alpha 10.19.12 | 09:10 am
